Skip to content

Stented Biliary Anastomosis in Living Donor Liver Transplantation

Randomized Controlled Clinical Trial Of Stented Versus Stentless Biliary Anastomosis In Living Donor Liver Transplantation

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03636321
Enrollment
30
Registered
2018-08-17
Start date
2018-08-10
Completion date
2019-11-10
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Transplant

Keywords

living donor liver transplantation, intraductal stent, biliary complications after liver transplantation

Brief summary

Determination of biliary complications in stented group compared to duct to duct anastomosis without stent

Detailed description

30 patients included in the study. patients will be randomly allocated in two equal groups. In group A anastomosis will be done on intraductal stent and in group B anastomosis done without stent .the patients will be followed for one year to compare the result of two groups as regard biliary complications.

Interventions

PROCEDUREliving donor liver transplantation with internal biliary stent

living donor liver transplantation without internal biliary stent

Sponsors

Ain Shams University
CollaboratorOTHER
Alaa Mstafa Hassan Sewefy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* adult patients eligible for a liver transplantation * patients' written informed consent signed.

Exclusion criteria

* biliary reconstruction requires a hepatico-jejunostomy for anatomical/biliary disease reason.

Design outcomes

Primary

MeasureTime frameDescription
biliary complications after living donor liver transplantationone yearincidence of biliary complications after living donor liver transplantation

Secondary

MeasureTime frameDescription
biliary complicationsone yeartypes of biliary complications
biliary related mortalityone yearmortality
hospital stayone monthhospital stay
time 2 biliary complicationsone yeartime 2 biliary complications
rate of cholangitis3 monthsrate of cholangitis

Other

MeasureTime frameDescription
skeletonization of duct10 hoursskeletonization of duct

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026